U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 102

Tests names and labsConditionsGenes, analytes, and microbesMethods

Fragile X Syndrome, Repeat Number Analysis with Reflex to Methylation Analysis

Institute for Genomic Medicine (IGM) Clinical Laboratory Nationwide Children's Hospital
United States
61
  • M Methylation analysis
  • T Targeted variant analysis

Fragile X Tremor-Ataxia Syndrome

Genetics Laboratory Shodair Children's Hospital
United States
11
  • M Methylation analysis
  • T Targeted variant analysis

Fragile X Syndrome and FMR1-Related Disorders

Clinical Molecular Genetics Laboratory Johns Hopkins All Children's Hospital
United States
21
  • T Targeted variant analysis

Fragile X Syndrome, Mol. Analysis

Mayo Clinic Laboratories Mayo Clinic
United States
41
  • M Methylation analysis
  • T Targeted variant analysis

Fragile X syndrome testing

Bionano Laboratories
United States
61
  • T Targeted variant analysis

Fragile X syndrome and associated disorders

Genomic Engenharia Molecular
Brazil
21
  • X Mutation scanning of select exons

Infertility Panel

Centogene US, LLC - The Rare Disease Company
United States
243238
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CentoScreen

Centogene US, LLC - The Rare Disease Company
United States
316314
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Intellectual Disability Panel

Centogene US, LLC - The Rare Disease Company
United States
777770
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

FMR1 - Sanger sequencing

Centogene US, LLC - The Rare Disease Company
United States
31
  • C Sequence analysis of the entire coding region

FMR1 - MLPA

Centogene US, LLC - The Rare Disease Company
United States
31
  • D Deletion/duplication analysis

FMR1 - Repeat expansion analysis

Centogene US, LLC - The Rare Disease Company
United States
31
  • T Targeted variant analysis

Infertility Panel

Centogene AG - the Rare Disease Company
Germany
243238
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CentoScreen

Centogene AG - the Rare Disease Company
Germany
316314
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

FMR1 - Repeat expansion analysis

Centogene AG - the Rare Disease Company
Germany
31
  • T Targeted variant analysis

FMR1 - MLPA

Centogene AG - the Rare Disease Company
Germany
31
  • D Deletion/duplication analysis

FMR1 - Sanger sequencing

Centogene AG - the Rare Disease Company
Germany
31
  • C Sequence analysis of the entire coding region

Intellectual Disability Panel

Centogene AG - the Rare Disease Company
Germany
777770
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Autism Spectrum Disorders (ASD) Panel

PreventionGenetics
United States
224170
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Fragile X tremor/ataxia syndrome, 300623, X-linked dominant; FXTAS (Fragile X-associated tremor/ataxia syndrome) (MLPA)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • D Deletion/duplication analysis

Results: 1 to 20 of 102

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.